1. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons;Akerud;J. Neurochem.,1999
2. Intraputamenal infusion of r-metHUGDNF for the treatment of Parkinson’s disease;Boyd,2004
3. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis;Crystal;Human Gene Therapy,2004
4. Dass, B., et al., submitted for publication. Dose-related transgene expression and bioactivity in the monkey nigrostriatal system following intrastriatal delivery of AAV2–Neurturin (CERE-120). Journal of Comparative Neurology.
5. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation;During;Hum Gene Ther.,2001